Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism

A side-effect of treatment with antipsychotic drugs for schizophrenia is increased body fat, which leads to further morbidity and poor adherence to treatment. The 5-hydroxytryptamine 2C receptor (5-HT2C) has been associated with this effect; we aimed to establish whether a genetic polymorphism of the promoter region of this receptor affects weight gain after drug treatment in first-episode patients with schizophrenia. We noted significantly less weight gain in patients with the −759T variant allele (p=0·0003) than in those without this allele, who were more likely to have substantial (>7%) weight gain (p=0·002). We have identified a genetic factor that is associated with antipsychotic drug-induced weight gain.